{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:17:41Z","timestamp":1791919061764,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tumor invasion and metastasis are strongly influenced by cell membrane fluidity, regulated by lipid metabolism. In choroidal melanoma (CM), a highly metastatic cancer, the relationship between lipid metabolism, membrane fluidity, and metastatic mechanisms remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We examined m\n                      <jats:sup>6<\/jats:sup>\n                      A methylation in CM patient samples. Lipidomic profiling was performed in control, METTL14-silenced, or SCD1-silenced CM cells. Transcriptomics were analyzed after METTL14 manipulation. Transmission electron microscopy assessed ultrastructural changes, while multiplex immunohistochemistry validated the clinical relevance of the MAFG\u2013METTL14\u2013SCD1 axis. The anti-metastatic effect of combining the SCD1 inhibitor aramchol with a stearate-rich diet (S-HFD) was tested in nude mouse CM metastasis models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Lipidomics revealed that SCD1 promotes CM progression via cardiolipin and fatty acid metabolism pathways. Silencing SCD1 reduced membrane fluidity, while its upregulation in CM was driven by METTL14-mediated m\n                      <jats:sup>6<\/jats:sup>\n                      A methylation at the 2492 mRNA site. Elevated MAFG expression further activated METTL14. Mechanistically, this MAFG\u2013METTL14\u2013SCD1 axis enhanced CM invasiveness. In preclinical models, aramchol combined with S-HFD markedly suppressed distant metastasis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study identifies SCD1-mediated lipid remodeling as a key driver of enhanced membrane fluidity and metastatic potential in CM. Inhibition of SCD1 increases lipid saturation, reduces membrane fluidity, induces oxidative stress, and suppresses liver and lung metastasis. The MAFG\u2013METTL14\u2013SCD1 axis thus represents a critical regulator of CM progression, and combined therapeutic targeting with aramchol and S-HFD offers promising translational potential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03595-1","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T23:15:28Z","timestamp":1764371728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Novel MAFG-METTL14-SCD1 axis regulates lipid metabolism mediating choroidal melanoma distant metastasis"],"prefix":"10.1186","volume":"44","author":[{"given":"Xi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiling","family":"Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"issue":"2","key":"3595_CR1","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/eye.2012.255","volume":"27","author":"SE Coupland","year":"2013","unstructured":"Coupland SE, Lake SL, Zeschnigk M, Damato BE. Molecular pathology of uveal melanoma. Eye (Lond). 2013;27(2):230\u201342.","journal-title":"Eye (Lond)"},{"issue":"2","key":"3595_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41571-022-00714-1","volume":"20","author":"RD Carvajal","year":"2023","unstructured":"Carvajal RD, Sacco JJ, Jager MJ, Eschelman DJ, Olofsson Bagge R, Harbour JW, et al. Advances in the clinical management of uveal melanoma. Nat Rev Clin Oncol. 2023;20(2):99\u2013115.","journal-title":"Nat Rev Clin Oncol"},{"key":"3595_CR3","doi-asserted-by":"publisher","first-page":"101041","DOI":"10.1016\/j.preteyeres.2022.101041","volume":"90","author":"ES Rantala","year":"2022","unstructured":"Rantala ES, Hernberg MM, Piperno-Neumann S, Grossniklaus HE, Kivel\u00e4 TT. Metastatic uveal melanoma: the final frontier. Prog Retin Eye Res. 2022;90:101041.","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"3595_CR4","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1167\/iovs.03-0538","volume":"44","author":"E Kujala","year":"2003","unstructured":"Kujala E, M\u00e4kitie T, Kivel\u00e4 T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44(11):4651\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"3595_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1755-3768.1982.tb08371.x","volume":"60","author":"OA Jensen","year":"1982","unstructured":"Jensen OA. Malignant melanomas of the human uvea: 25-year follow-up of cases in Denmark, 1943\u20131952. Acta Ophthalmol (Copenh). 1982;60(2):161\u201382.","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"7","key":"3595_CR6","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1158\/0008-5472.CAN-15-1970","volume":"76","author":"W Zhao","year":"2016","unstructured":"Zhao W, Prijic S, Urban BC, Tisza MJ, Zuo Y, Li L, et al. Candidate antimetastasis drugs suppress the metastatic capacity of breast cancer cells by reducing membrane fluidity. Cancer Res. 2016;76(7):2037\u201349.","journal-title":"Cancer Res"},{"issue":"6","key":"3595_CR7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41589-020-0529-6","volume":"16","author":"JH Lorent","year":"2020","unstructured":"Lorent JH, Levental KR, Ganesan L, Rivera-Longsworth G, Sezgin E, Doktorova M, et al. Plasma membranes are asymmetric in lipid unsaturation, packing and protein shape. Nat Chem Biol. 2020;16(6):644\u201352.","journal-title":"Nat Chem Biol"},{"issue":"8","key":"3595_CR8","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41580-023-00604-z","volume":"24","author":"T Sakuragi","year":"2023","unstructured":"Sakuragi T, Nagata S. Regulation of phospholipid distribution in the lipid bilayer by flippases and scramblases. Nat Rev Mol Cell Biol. 2023;24(8):576\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"3595_CR9","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","volume":"34","author":"M Martin-Perez","year":"2022","unstructured":"Martin-Perez M, Urdiroz-Urricelqui U, Bigas C, Benitah SA. The role of lipids in cancer progression and metastasis. Cell Metab. 2022;34(11):1675\u201399.","journal-title":"Cell Metab"},{"issue":"1","key":"3595_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s43018-023-00702-z","volume":"5","author":"FCE Vogel","year":"2024","unstructured":"Vogel FCE, Chaves-Filho AB, Schulze A. Lipids as mediators of cancer progression and metastasis. Nat Cancer. 2024;5(1):16\u201329.","journal-title":"Nat Cancer"},{"issue":"2","key":"3595_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41556-023-01341-3","volume":"26","author":"L Zhang","year":"2024","unstructured":"Zhang L, Zhao J, Lam SM, Chen L, Gao Y, Wang W, et al. Low-input lipidomics reveals lipid metabolism remodelling during early mammalian embryo development. Nat Cell Biol. 2024;26(2):278\u201393.","journal-title":"Nat Cell Biol"},{"key":"3595_CR12","doi-asserted-by":"crossref","unstructured":"Wang Y, Hu M, Cao J, Wang F, Han JR, Wu TW et al. ACSL4 and polyunsaturated lipids support metastatic extravasation and colonization. Cell. 2025;188(2):412\u2013429.","DOI":"10.1016\/j.cell.2024.10.047"},{"issue":"1","key":"3595_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13046-021-02211-2","volume":"41","author":"X Mao","year":"2022","unstructured":"Mao X, Lei H, Yi T, Su P, Tang S, Tong Y, et al. Lipid reprogramming induced by the TFEB-ERR\u03b1 axis enhanced membrane fluidity to promote EC progression. J Exp Clin Cancer Res. 2022;41(1):28.","journal-title":"J Exp Clin Cancer Res"},{"key":"3595_CR14","doi-asserted-by":"crossref","unstructured":"Liu Q, Zhang X, Qi J, Tian X, Dovjak E, Zhang J et al. Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC. Hepatology. 2025;81(4):1164\u20131180.","DOI":"10.1097\/HEP.0000000000000962"},{"issue":"22","key":"3595_CR15","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1158\/0008-5472.CAN-19-3382","volume":"80","author":"M Belleri","year":"2020","unstructured":"Belleri M, Paganini G, Coltrini D, Ronca R, Zizioli D, Corsini M, et al. \u03b2-Galactosylceramidase promotes melanoma growth via modulation of ceramide metabolism. Cancer Res. 2020;80(22):5011\u201323.","journal-title":"Cancer Res"},{"issue":"10","key":"3595_CR16","doi-asserted-by":"publisher","first-page":"111742","DOI":"10.1016\/j.celrep.2022.111742","volume":"41","author":"AH Janneh","year":"2022","unstructured":"Janneh AH, Kassir MF, Atilgan FC, Lee HG, Sheridan M, Oleinik N, et al. Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis. Cell Rep. 2022;41(10):111742.","journal-title":"Cell Rep"},{"issue":"6","key":"3595_CR17","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.trecan.2023.03.003","volume":"9","author":"U Sen","year":"2023","unstructured":"Sen U, Coleman C, Sen T. Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis. Trends Cancer. 2023;9(6):480\u20139.","journal-title":"Trends Cancer"},{"key":"3595_CR18","doi-asserted-by":"publisher","first-page":"102006","DOI":"10.1016\/j.redox.2021.102006","volume":"43","author":"G Luis","year":"2021","unstructured":"Luis G, Godfroid A, Nishiumi S, Cimino J, Blacher S, Maquoi E, et al. Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and fatty acid biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. Redox Biol. 2021;43:102006.","journal-title":"Redox Biol"},{"issue":"11","key":"3595_CR19","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.bbalip.2016.08.009","volume":"1861","author":"A Koeberle","year":"2016","unstructured":"Koeberle A, L\u00f6ser K, Th\u00fcrmer M. Stearoyl-CoA desaturase-1 and adaptive stress signaling. Biochim Biophys Acta. 2016;1861(11):1719\u201326.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"3595_CR20","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1016\/j.ymthe.2022.03.015","volume":"30","author":"HH Liu","year":"2022","unstructured":"Liu HH, Xu Y, Li CJ, Hsu SJ, Lin XH, Zhang R, et al. An SCD1-dependent mechanoresponsive pathway promotes HCC invasion and metastasis through lipid metabolic reprogramming. Mol Ther. 2022;30(7):2554\u201367.","journal-title":"Mol Ther"},{"issue":"2","key":"3595_CR21","doi-asserted-by":"publisher","first-page":"e1587","DOI":"10.1002\/ctm2.1587","volume":"14","author":"G Che","year":"2024","unstructured":"Che G, Wang W, Wang J, He C, Yin J, Chen Z, et al. Sulfotransferase SULT2B1 facilitates colon cancer metastasis by promoting SCD1-mediated lipid metabolism. Clin Transl Med. 2024;14(2):e1587.","journal-title":"Clin Transl Med"},{"issue":"6","key":"3595_CR22","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.ymthe.2022.02.021","volume":"30","author":"Y Yang","year":"2022","unstructured":"Yang Y, Cai J, Yang X, Wang K, Sun K, Yang Z, et al. Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma. Mol Ther. 2022;30(6):2342\u201353.","journal-title":"Mol Ther"},{"issue":"2","key":"3595_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s42255-024-00978-0","volume":"6","author":"W Xia","year":"2024","unstructured":"Xia W, Veeragandham P, Cao Y, Xu Y, Rhyne TE, Qian J, et al. Obesity causes mitochondrial fragmentation and dysfunction in white adipocytes due to RalA activation. Nat Metab. 2024;6(2):273\u201389.","journal-title":"Nat Metab"},{"issue":"11","key":"3595_CR24","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.tem.2023.08.011","volume":"34","author":"O G\u00f6ransson","year":"2023","unstructured":"G\u00f6ransson O, Kopietz F, Rider MH. Metabolic control by AMPK in white adipose tissue. Trends Endocrinol Metab. 2023;34(11):704\u201317.","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"3595_CR25","doi-asserted-by":"publisher","first-page":"e2204190","DOI":"10.1002\/advs.202204190","volume":"10","author":"Y He","year":"2023","unstructured":"He Y, B\u2019Nai Taub A, Yu L, Yao Y, Zhang R, Zahr T, et al. PPAR\u03b3 acetylation orchestrates adipose plasticity and metabolic rhythms. Adv Sci (Weinh). 2023;10(2):e2204190.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"3595_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","volume":"19","author":"T Wang","year":"2020","unstructured":"Wang T, Kong S, Tao M, Ju S. The potential role of RNA N6-methyladenosine in cancer progression. Mol Cancer. 2020;19(1):88.","journal-title":"Mol Cancer"},{"key":"3595_CR27","doi-asserted-by":"crossref","unstructured":"Sun B, Wang G, Chen G, Zhang Y, Yang R, Hua H et al. GNAO1 overexpression promotes neural differentiation of glioma stem-like cells and reduces tumorigenicity through TRIM21\/CREB\/HES1 axis. Oncogene. 2025;44(7):450\u2013461.","DOI":"10.1038\/s41388-024-03234-7"},{"key":"3595_CR28","doi-asserted-by":"crossref","unstructured":"Gao ZX, Li CL, Zhang H, Zhang GH, Zhang Y, Guo XY et al. LINC00882, transcriptionally activated by CEBP-\u03b2 and post-transcriptionally stabilized by METTL14-mediated m(6)A modification, exerts tumorigenesis by promoting PABPC1-mediated stabilization of ELK3 mRNA. Oncogene. 2025;44(6):363\u2013377.","DOI":"10.1038\/s41388-024-03225-8"},{"issue":"1","key":"3595_CR29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12943-019-1088-x","volume":"18","author":"R Jia","year":"2019","unstructured":"Jia R, Chai P, Wang S, Sun B, Xu Y, Yang Y, et al. m(6)A modification suppresses ocular melanoma through modulating HINT2 mRNA translation. Mol Cancer. 2019;18(1):161.","journal-title":"Mol Cancer"},{"issue":"22","key":"3595_CR30","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.1111\/jcmm.17577","volume":"26","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhang X, Liu T, Zhang Z, Piao C, Ning H. METTL14 promotes migration and invasion of choroidal melanoma by targeting RUNX2 mRNA via m6A modification. J Cell Mol Med. 2022;26(22):5602\u201313.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"3595_CR31","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.gendis.2020.07.011","volume":"8","author":"B Zhang","year":"2021","unstructured":"Zhang B, Jiang H, Dong Z, Sun A, Ge J. The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases. Genes Dis. 2021;8(6):746\u201358.","journal-title":"Genes Dis"},{"key":"3595_CR32","doi-asserted-by":"crossref","unstructured":"Zhao L, Guo J, Xu S, Duan M, Liu B, Zhao H et al. Abnormal changes in metabolites caused by m(6)A methylation modification: the leading factors that induce the formation of immunosuppressive tumor microenvironment and their promising potential for clinical application. J Adv Res. 2025;70:159\u2013186.","DOI":"10.1016\/j.jare.2024.04.016"},{"issue":"1","key":"3595_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12974-024-03279-1","volume":"21","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Liu X, Lu H, Li N, Meng J, Huang J, et al. m6A-methylase METTL3 promotes retinal angiogenesis through modulation of metabolic reprogramming in RPE cells. J Neuroinflammation. 2024;21(1):289.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3595_CR34","doi-asserted-by":"publisher","first-page":"5410","DOI":"10.1038\/s41467-024-49745-5","volume":"15","author":"C Wang","year":"2024","unstructured":"Wang C, Tanizawa H, Hill C, Havas A, Zhang Q, Liao L, et al. METTL3-mediated chromatin contacts promote stress granule phase separation through metabolic reprogramming during senescence. Nat Commun. 2024;15(1):5410.","journal-title":"Nat Commun"},{"issue":"8","key":"3595_CR35","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s42255-022-00622-9","volume":"4","author":"H Peng","year":"2022","unstructured":"Peng H, Chen B, Wei W, Guo S, Han H, Yang C, et al. N(6)-methyladenosine (m(6)A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation. Nat Metab. 2022;4(8):1041\u201354.","journal-title":"Nat Metab"},{"issue":"5","key":"3595_CR36","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.bbalip.2018.02.003","volume":"1863","author":"A Chen","year":"2018","unstructured":"Chen A, Chen X, Cheng S, Shu L, Yan M, Yao L, et al. FTO promotes SREBP1c maturation and enhances CIDEC transcription during lipid accumulation in HepG2 cells. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863(5):538\u201348.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"3595_CR37","doi-asserted-by":"crossref","unstructured":"Chen H, Liu C, Cui S, Xia Y, Zhang K, Cheng H et al. Intermittent fasting triggers interorgan communication to suppress hair follicle regeneration. Cell. 2025;188(1):157\u2013174.","DOI":"10.1016\/j.cell.2024.11.004"},{"issue":"4","key":"3595_CR38","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3109\/15412555.2012.668581","volume":"9","author":"S Gangopadhyay","year":"2012","unstructured":"Gangopadhyay S, Vijayan VK, Bansal SK. Lipids of erythrocyte membranes of COPD patients: a quantitative and qualitative study. Copd. 2012;9(4):322\u201331.","journal-title":"Copd"},{"issue":"3","key":"3595_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10867-017-9459-2","volume":"43","author":"LT Gew","year":"2017","unstructured":"Gew LT, Misran M. Interaction between C18 fatty acids and DOPE PEG2000 in Langmuir monolayers: effect of degree of unsaturation. J Biol Phys. 2017;43(3):397\u2013414.","journal-title":"J Biol Phys"},{"key":"3595_CR40","doi-asserted-by":"publisher","first-page":"215884","DOI":"10.1016\/j.canlet.2022.215884","volume":"547","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhou X, Lei Y, Chu Y, Yu X, Tong Q, et al. NNMT contributes to high metastasis of triple negative breast cancer by enhancing PP2A\/MEK\/ERK\/c-Jun\/ABCA1 pathway mediated membrane fluidity. Cancer Lett. 2022;547:215884.","journal-title":"Cancer Lett"},{"issue":"6","key":"3595_CR41","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/RLU.0000000000000740","volume":"40","author":"E Kurtipek","year":"2015","unstructured":"Kurtipek E, \u00c7ayci M, D\u00fczg\u00fcn N, Esme H, Terzi Y, Bakdik S, et al. (18)F-FDG PET\/CT mean SUV and metabolic tumor volume for mean survival time in non-small cell lung cancer. Clin Nucl Med. 2015;40(6):459\u201363.","journal-title":"Clin Nucl Med"},{"issue":"5","key":"3595_CR42","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1378\/chest.09-2356","volume":"137","author":"VS Nair","year":"2010","unstructured":"Nair VS, Barnett PG, Ananth L, Gould MK. PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer. Chest. 2010;137(5):1150\u20136.","journal-title":"Chest"},{"issue":"10","key":"3595_CR43","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/s41591-021-01495-3","volume":"27","author":"V Ratziu","year":"2021","unstructured":"Ratziu V, de Guevara L, Safadi R, Poordad F, Fuster F, Flores-Figueroa J, et al. Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial. Nat Med. 2021;27(10):1825\u201335.","journal-title":"Nat Med"},{"issue":"49","key":"3595_CR44","doi-asserted-by":"publisher","first-page":"22562","DOI":"10.1021\/jacs.2c08602","volume":"144","author":"H Bian","year":"2022","unstructured":"Bian H, Ma D, Pan F, Zhang X, Xin K, Zhang X, et al. Cardiolipin-Targeted NIR-II fluorophore causes avalanche effects for Re-Engaging cancer apoptosis and inhibiting metastasis. J Am Chem Soc. 2022;144(49):22562\u201373.","journal-title":"J Am Chem Soc"},{"issue":"6","key":"3595_CR45","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ccell.2017.11.011","volume":"32","author":"Y Guri","year":"2017","unstructured":"Guri Y, Colombi M, Dazert E, Hindupur SK, Roszik J, Moes S, et al. mTORC2 promotes tumorigenesis via lipid synthesis. Cancer Cell. 2017;32(6):807\u2013e2312.","journal-title":"Cancer Cell"},{"issue":"7","key":"3595_CR46","doi-asserted-by":"publisher","first-page":"e1766","DOI":"10.1002\/ctm2.1766","volume":"14","author":"L Li","year":"2024","unstructured":"Li L, Tang Q, Ge J, Wang D, Mo Y, Zhang Y, et al. METTL14 promotes lipid metabolism reprogramming and sustains nasopharyngeal carcinoma progression via enhancing m(6)A modification of ANKRD22 mRNA. Clin Transl Med. 2024;14(7):e1766.","journal-title":"Clin Transl Med"},{"issue":"1","key":"3595_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12943-024-01962-8","volume":"23","author":"T Jiang","year":"2024","unstructured":"Jiang T, Qi J, Xue Z, Liu B, Liu J, Hu Q, et al. The m(6)A modification mediated-lncRNA POU6F2-AS1 reprograms fatty acid metabolism and facilitates the growth of colorectal cancer via upregulation of FASN. Mol Cancer. 2024;23(1):55.","journal-title":"Mol Cancer"},{"issue":"3","key":"3595_CR48","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.cell.2015.03.003","volume":"161","author":"JI Fuxman Bass","year":"2015","unstructured":"Fuxman Bass JI, Sahni N, Shrestha S, Garcia-Gonzalez A, Mori A, Bhat N, et al. Human gene-centered transcription factor networks for enhancers and disease variants. Cell. 2015;161(3):661\u201373.","journal-title":"Cell"},{"issue":"1","key":"3595_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40364-023-00457-w","volume":"11","author":"Y Deng","year":"2023","unstructured":"Deng Y, Lu L, Zhang H, Fu Y, Liu T, Chen Y. The role and regulation of Maf proteins in cancer. Biomark Res. 2023;11(1):17.","journal-title":"Biomark Res"},{"key":"3595_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2018.06.005","volume":"200","author":"O Vera-Puente","year":"2018","unstructured":"Vera-Puente O, Rodriguez-Antolin C, Salgado-Figueroa A, Michalska P, Pernia O, Reid BM, et al. MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species. Transl Res. 2018;200:1\u201317.","journal-title":"Transl Res"},{"issue":"2","key":"3595_CR51","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1053\/j.gastro.2018.04.032","volume":"155","author":"T Liu","year":"2018","unstructured":"Liu T, Yang H, Fan W, Tu J, Li TWH, Wang J, et al. Mechanisms of MAFG dysregulation in cholestatic liver injury and development of liver cancer. Gastroenterology. 2018;155(2):557\u2013e7114.","journal-title":"Gastroenterology"},{"key":"3595_CR52","doi-asserted-by":"crossref","unstructured":"Vera O, Martinez M, Soto-Vargas Z, Wang K, Xu X, Ruiz-Buceta S et al. The small MAF transcription factor MAFG co-opts MITF to promote melanoma progression. BioRxiv. [Preprint]. 2024 Sep","DOI":"10.1101\/2024.09.03.611024"},{"issue":"9","key":"3595_CR53","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41418-024-01322-5","volume":"31","author":"Y Deng","year":"2024","unstructured":"Deng Y, Lu L, Zhu D, Zhang H, Fu Y, Tan Y, et al. MafG\/MYH9-LCN2 axis promotes liver fibrosis through inhibiting ferroptosis of hepatic stellate cells. Cell Death Differ. 2024;31(9):1127\u201339.","journal-title":"Cell Death Differ"},{"issue":"11","key":"3595_CR54","first-page":"a041079","volume":"14","author":"DR Green","year":"2022","unstructured":"Green DR. Nonapoptotic cell death pathways. Cold Spring Harb Perspect Biol. 2022;14(11):a041079.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"3595_CR55","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.devcel.2006.04.008","volume":"10","author":"ZT Schafer","year":"2006","unstructured":"Schafer ZT, Kornbluth S. The apoptosome: physiological, developmental, and pathological modes of regulation. Dev Cell. 2006;10(5):549\u201361.","journal-title":"Dev Cell"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03595-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03595-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03595-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T06:05:16Z","timestamp":1767074716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-025-03595-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3595"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03595-1","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"20 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent, and ethical approval was issued by the ethics committee of The First Hospital of China Medical University (approval No.: AF-SOP\u201007\u20101.1\u201001). All experiments involving animals were conducted according to the ethical policies and procedures approved by the Ethics Committee of the First Hospital of China Medical University (CMU2021090). All animal protocols were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and was approved by the China Medical University Animal Care and Use Committee. In the mouse model, liver and lung metastases were induced via tail vein injection, without surpassing the maximum permissible tumor burden.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"334"}}